Biocon Biologics secures US Market entry date for Bmab 1200
Biocon Biologics has signed a settlement and license agreement with Janssen Biotech Inc., and Johnson & Johnson (collectively known as Janssen) that clears the way to commercialize its Bmab 1200,…
Lire la suite / Read more
![[Vidéo news] Atelier du RUSI sur les risques de financement de la prolifération](https://www.maurice-info.mu/wp-content/uploads/2025/01/Dr-Jyoti-Jeetun-expliquant-limportance-de-cet-atelier-pour-Maurice.jpg)
![[Vidéo news] Fabrice David a dit](https://www.maurice-info.mu/wp-content/uploads/2025/01/Fabrice-David.jpg)
![[Vidéo News] Dr Jyoti Jeetun a dit](https://www.maurice-info.mu/wp-content/uploads/2025/01/Dr-Jyoti-Jeetun.jpg)
